Literature DB >> 19225918

Current status and perspectives of brachytherapy for head and neck cancer.

Hitoshi Shibuya1.   

Abstract

Brachytherapy delivers a high radiation dose to a limited volume while sparing surrounding normal tissues. In head and neck cancer, severe soft-tissue damage and bone damage to the mandible has decreased markedly since the introduction of computer dosimetry and the use of spacers during treatment. For the curative treatment of head and neck cancer, the selection of brachytherapy sources from among the several linear and small permanent implant sources available, not only according to the tumor site but also according to the patient's physical and mental condition is important. Following the successful treatment of early head and neck cancer by brachytherapy, two major problems and one minor problem may confront the physician. The major problems are neck node metastasis and a second primary cancer of the respiratory tract or upper digestive tract, and the minor problem is radiation-induced cancer.

Entities:  

Mesh:

Year:  2009        PMID: 19225918     DOI: 10.1007/s10147-008-0859-y

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  35 in total

Review 1.  Oral leukoplakia: a clinicopathological review.

Authors:  I van der Waal; K P Schepman; E H van der Meij; L E Smeele
Journal:  Oral Oncol       Date:  1997-09       Impact factor: 5.337

2.  Exclusive low-dose-rate brachytherapy in 279 patients with T2N0 mobile tongue carcinoma.

Authors:  Céline Bourgier; Bernard Coche-Déquéant; Charles Fournier; Bernard Castelain; Bernard Prévost; Jean-Louis Lefebvre; Eric Lartigau
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-01       Impact factor: 7.038

3.  High-dose rate interstitial brachytherapy for stage I-II tongue cancer.

Authors:  M Umeda; H Komatsubara; N Nishimatsu; S Yokoo; Y Shibuya; T Komori
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2000-11

4.  The effect of age on survival and quality of life in elderly head and neck cancer patients: a long-term prospective study.

Authors:  Marc P van der Schroeff; Wynia Derks; Gerrit Jan Hordijk; Rob J de Leeuw
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-11-11       Impact factor: 2.503

5.  Early stage carcinoma of oral tongue: prognostic factors for local control and survival.

Authors:  N Al-Rajhi; Y Khafaga; J El-Husseiny; M Saleem; W Mourad; A Al-Otieschan; A Al-Amro
Journal:  Oral Oncol       Date:  2000-11       Impact factor: 5.337

6.  Brachytherapy for stage I & II oral tongue cancer: an analysis of past cases focusing on control and complications.

Authors:  H Shibuya; M Hoshina; M Takeda; S Matsumoto; S Suzuki; N Okada
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-04-30       Impact factor: 7.038

7.  Leukoplakia-associated multiple carcinomas in patients with tongue carcinoma.

Authors:  H Shibuya; T Amagasa; K Seto; K Ishibashi; J Horiuchi; S Suzuki
Journal:  Cancer       Date:  1986-02-15       Impact factor: 6.860

8.  Factors affecting mandibular complications in low dose rate brachytherapy for oral tongue carcinoma with special reference to spacer.

Authors:  M Miura; M Takeda; T Sasaki; T Inoue; T Nakayama; H Fukuda; A Hoshi; M Hoshina; H Shibuya
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-07-01       Impact factor: 7.038

9.  The addition of mood and anxiety domains to the University of Washington quality of life scale.

Authors:  Simon N Rogers; Suzanne Gwanne; Derek Lowe; Gerry Humphris; Beven Yueh; Ernest A Weymuller
Journal:  Head Neck       Date:  2002-06       Impact factor: 3.147

10.  Role of interstitial brachytherapy in oral and oropharyngeal carcinoma: reflection of a series of 1344 patients treated at the time of initial presentation.

Authors:  M Pernot; S Hoffstetter; D Peiffert; P Aletti; M Lapeyre; C Marchal; E Luporsi; P Bey; V L Nancy
Journal:  Otolaryngol Head Neck Surg       Date:  1996-12       Impact factor: 5.591

View more
  8 in total

1.  Customized individual applicators for endocavitary brachytherapy in patients with cancers of the nasal cavity, sinonasal region and nasopharynx.

Authors:  Basel Al Kadah; Marcus Niewald; George Papaspyrou; Yvonne Dzierma; Mathias Schneider; Bernhard Schick
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-04-24       Impact factor: 2.503

Review 2.  Systematic review of hyperbaric oxygen therapy for the treatment of non-neurological soft tissue radiation-related injuries.

Authors:  Benjamin L Hoggan; Alun L Cameron
Journal:  Support Care Cancer       Date:  2014-03-29       Impact factor: 3.603

3.  Chronological shifts and changing causes of death after radiotherapy for early-stage oral cancer.

Authors:  Rina Fujisawa; Hitoshi Shibuya; Naoki Harata; Keiko Yuasa-Nakagawa; Kazuma Toda; Keiji Hayashi
Journal:  Int J Clin Oncol       Date:  2013-02-02       Impact factor: 3.402

4.  Dose-response effect of human equivalent radiation in the mandible.

Authors:  Laura A Monson; X Lin Jing; Alexis Donneys; Aaron S Farberg; Steven R Buchman
Journal:  J Craniofac Surg       Date:  2013-09       Impact factor: 1.046

Review 5.  Head and neck cancer management and cancer stem cells implication.

Authors:  Osama A Elkashty; Ramy Ashry; Simon D Tran
Journal:  Saudi Dent J       Date:  2019-06-10

6.  Laparoscopic spacer placement for bulky lymph node metastasis of cervical cancer: A case report.

Authors:  Airi Kuruma; Michiko Kodama; Ai Miyoshi; Fumiaki Isohashi; Aska Toda; Satoshi Nakagawa; Yasuto Kinose; Tsuyoshi Takiuchi; Eiji Kobayashi; Kae Hashimoto; Yutaka Ueda; Kenjiro Sawada; Tadashi Kimura
Journal:  Gynecol Oncol Rep       Date:  2022-09-27

7.  High dose rate versus low dose rate brachytherapy for oral cancer--a meta-analysis of clinical trials.

Authors:  Zhenxing Liu; Shengyun Huang; Dongsheng Zhang
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.240

8.  198Au grain implantation for early tongue cancer in patients of advanced age or poor performance status.

Authors:  Yoshiharu Ryu; Hitoshi Shibuya; Keiji Hayashi
Journal:  J Radiat Res       Date:  2013-05-17       Impact factor: 2.724

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.